本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

enVVeno Medical Corp.

0.4200
-0.2330-35.68%
盘前0.3976-0.0224-5.33%07:06 EST
成交量:566.56万
成交额:226.83万
市值:849.08万
市盈率:-0.39
高:0.4320
开:0.4000
低:0.3610
收:0.6530
52周最高:5.62
52周最低:0.3610
股本:2,021.62万
流通股本:1,908.56万
量比:31.02
换手率:29.69%
股息:- -
股息率:- -
每股收益(TTM):-1.0815
每股收益(LYR):-1.2728
净资产收益率:-57.19%
总资产收益率:-35.12%
市净率:0.29
市盈率(LYR):-0.33

数据加载中...

2024/05/10

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/05/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/04/24

重要事件披露

Form 8-K - Current report
2024/03/06

重要事件披露

Form 8-K - Current report
2024/02/29

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/23

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/15

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/12/08

重要事件披露

Form 8-K - Current report
2023/11/16

重要事件披露

Form 8-K - Current report
2023/11/02

SEC问询函

Form CORRESP - Correspondence
2023/10/26

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/10/12

重要事件披露

Form 8-K - Current report
2023/08/22

SEC问询函

Form CORRESP - Correspondence
2023/07/31

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/05/26

交易所摘牌声明

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2023/04/28

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/03/02

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/12/06

重要事件披露

8-K - Current report